Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase EARLY_PHASE1 1

Status

Recruiting 3Completed 1

Sponsor Class

OTHER 3FED 1

Study Type

Interventional 4Observational 3

Sponsor

Cancer Type

Thoracic 4Breast 4Tumor-Agnostic 3Gynecologic 2Gastrointestinal 2CNS 2Other hematologic neoplasm 1Dermatologic 1

Conditions

Lung Neoplasms 3Tobacco Use Disorder 1Substance-Related Disorders 1Smoking 1Lung Cancer Screening 1

Interventions

Carboplatin 1152Cisplatin 876Pemetrexed 834pembrolizumab 608Paclitaxel 598Docetaxel 535Gemcitabine 424Radiotherapy 377Erlotinib Hydrochloride 367Nivolumab 322Bevacizumab 322Etoposide 295durvalumab 254Drug Therapy 233osimertinib 218atezolizumab 208Radiosurgery 190Gefitinib 177Vinorelbine 145130-nm albumin-bound paclitaxel 124Magnetic Resonance Spectroscopy 121Ipilimumab 118Cetuximab 113anlotinib 104tislelizumab 103Topotecan 101Cyclophosphamide 101Taxes 99Irinotecan 95Albumin-Bound Paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Focus Groups × Thoracic × Clear all
NCT07382557 2026-02-03

Adaptation and Pilot Testing of a Lung Cancer Screening Decision Aid for Patients From a Safety-Net Healthcare System

M.D. Anderson Cancer Center

Phase NA Recruiting
360 enrolled
Thoracic

Lung Neoplasms

NCT05833334 2026-01-30

HHS

Dartmouth-Hitchcock Medical Center

Phase NA Recruiting
172 enrolled
Thoracic

Lung Neoplasms, Smoking

NCT02914899 2025-11-21

Informing the Adaptation of a CHW Model to Facilitate Lung Cancer Screening for the Chinese Community

Memorial Sloan Kettering Cancer Center

Phase EARLY_PHASE1 Completed
99 enrolled
Thoracic

Lung Cancer Screening

NCT06432985 2025-09-30

CM_TUD_Cancer

VA Office of Research and Development

Phase NA Recruiting
108 enrolled
Thoracic

Lung Neoplasms, Tobacco Use Disorder, Substance-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡